Real-time enrollment status for this copd clinical trial
Current Status
Completed
Checked: April 17, 2026 at 3:26 AM UTC
| NCT Number | NCT06067828 |
| Recruiting Status | Completed |
| Condition | COPD |
| Phase | Clinical Trial |
| Target Enrollment | 180 participants |
| Active Locations | 7 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | March 5, 2026 (Mar 5, 2026) |
As of April 17, 2026: Clinical trial NCT06067828 is currently completed participants. This clinical trial study for copd is not currently accepting new participants at 7 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06067828 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06067828 was last updated Mar 5, 2026 (March 5, 2026). HelloStudys verifies this status automatically.